MasterClass: GAD Care Reimagined: Current Best Practices and the Emerging Role of Psychedelics
90 min
Friday, September 18, 2026
10:15 AM - 11:45 AM
Although effective treatments exist for generalized anxiety disorder, many patients continue to experience significant symptoms and functional impairment. This session reviews current standards of care, explores the neurobiology and therapeutic rationale for investigational psychedelic compounds, and evaluates emerging evidence to help clinicians prepare for future treatment advances.
Supported by an educational grant from Definium Therapeutics.
Supported by an educational grant from Definium Therapeutics.
-
Speaker
-
Brittany Albright MD, MPH -
Andrew Penn MS, PMHNP-BC
-
-
Room
- Great Hall A